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status performed in 72 (75%) pts. median 4 (0-40) in other 24 
(25%) NX; diameter of the cylinder used in 76 (84%) pts. was 
3-4 cm remaining 20 (26%) diameter 1-2. Only 3 (3%) pts 
resulted disease progression. Psychological evaluation was 
performed on 69 pts (Median age 61; 44 - 71), the other 27 
cannot be estimated because not interested. In the first area 
test showed for a third of pts a change of social relations 
judged value "from much up to very much", while in half of 
respondents, there was same value in personal sphere. 
Considering couple intimacy the 71% of women had 
undergone a change, and 81% reported decrease of sexual 
desire. In third area half of pts said they were informed 
about impact of BRT on sexual life evaluating changes 
induced by it " from much up to very much"; 71% of women 
surveyed have been recommended to have therapeutic 
relationships, 73% of respondents reported painful 
intercourse and 91% of pts found it unsatisfactory. 13% of pts 
has explicitly requested psychological support 
 
Conclusion: Apart from grading and lymph node status, BRT 
of vaginal cuff is effective in preventing local recurrence. 
Despite of use of larger diameter cylinders, remains problem 
of toxicity management post BRT. Analysis of impact on 
quality of life of these pts causes several issues: whether 
treatment should always be recommended, if we have to 
review informed consent and if a psychological support pre-
treatment is necessary. An appropriate supportive therapy 
during and after BRT is always necessary 
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Purpose or Objective: To evaluate the factors associated 
with uterine perforation in a population treated with tandem 
and ovoids high-dose rate tridimensional (HDR 3D BT) 
brachytherapy for gynecological cancer, without 
ultrasonographic guidance. 
 
Material and Methods: Computed tomographic images used 
for HDR 3D BT of 47 cases of gynecological cancer (46 
cervical and 1 endometrial cancer) were studied. The 
perforation rate (PR) was determined by software Oncentra 
MasterPlan V3.3 (Veenendaal, Netherlands). The categorical 
variables tested were: bladder filling (empty vs. full), age 
(≤60 years vs. >60 years), uterine lateral position (left or 
right vs. central) and uterine sagittal position (anterior vs 
central or retrograde). For statistical analysis, multiple 
logistic regression was performed (SPSS V.20). 
 
Results: The study evaluated 186 insertions. The treatment 
was performed using 4 fractions of 7 Gy in 45 patients (95.7%) 
and 3 fractions of 7 Gy in two patients (4.3%). Median age 
was 47 years (range, 24 - 82). The total PR was 21.5.% (40 
events). The site of the perforation was: 67.5% posterior wall 
(27 cases), 17.5% left lateral (7 cases), 7.5% cranial (3 cases), 
5% anterior wall (2 cases) and 2.5% right lateral (1 case). In 
forty-three cases (91.5%), the perforation occurred in the 
opposite direction of the uterus anatomic position. Factors 
that increased the PR in univariate analysis were: empty 
bladder (p<0.001), anterior uterine position (p=0.010) and 
age (p=0.010). In multivariate analysis, only empty bladder 
remained as an independent prognostic factor for perforation 
(p=0.002). 
 
Conclusion: In our series, the modifiable factor empty 
bladder correlated with uterine perforation. Although uterine 
anatomic position did not influenced significantly the 
incidence of uterine perforation, it determined the direction 
of the perforation in more than 90% of the cases. Our data 
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Purpose or Objective: To compare CT-based dose 
distribution to CTV and organs at risk (OAR) of HDR vaginal 
vault brachytherapy (VVB) with stump applicator according to 
2 prescription modes: standard prescription to 5 mm from the 
applicator surface versus individualised prescription 
according to the thickness of the vaginal wall. 
 
Material and Methods: This study was performed between 
January 2013 and December 2014, on a cohort of 61 
consecutive patients (pts) with endometrial cancer referred 
for a post operative HDR VVB. Mean age was 68 years. 
According to FIGO stage, 21% were Ia G3, 54% Ib, 10% II and 
15% III. 24 Gy in 4 fractions were delivered as sole treatment 
in 33 pts; whereas 28 pts received 10 Gy in 2 fractions after 
45 Gy pelvic irradiation. The CT was performed with 
applicator in situ before the first fraction. The size of the 
applicator was determined according to the clinical 
examination, but was modified if significant air gaps were 
observed on CT. CTV was defined as the vaginal vault and the 
upper third of the vagina; intestine as the lower third of the 
peritoneal cavity. Bladder and rectum were delineated 
entirely. Using brachyvision®, the Standard Plan (SP) was 
calculated for delivering the fraction dose (FD) on a 
reference line placed at 5 mm of the applicator surface 
irrespective of the location of OAR. The Individualised Plan 
(IP) was calculated from a line that conformed to the outer 
contour of the CTV with the following constraints: CTVD90 = 
FD+/-5%, D2cc to rectum and bladder ≤ FD and D2cc to 
Intestine ≤ (FD-1Gy). The CTVD90 and D2cc to OAR were used 
for the plans comparison 
 
Results:According to constraints (in, above, under), 6 
different groups could be defined: Gp1 : D90 and D2cc in; 
Gp2 : D90 in and D2 cc above; Gp3 D90 and D2cc above; Gp4 
: D90 above and D2cc in ; Gp5 D90 under and D2cc in ; Gp 
D90 under and D2cc above. Results of the comparison are 




Conclusion: CT-based individualised single source line HDR 
VVB was feasible and resulted in optimisation of the dose 
distribution to CTV and/or OAR in the majority of cases. In 
only 20% of cases, individualisation didn’t change the dose 
distribution. Consequently, CT-based dosimetry became the 
standard procedure in our department since January 2015. 
The assessment of the clinical impact will be the next step. 
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Purpose or Objective: The aim of the study is to evaluate 
the differences in dosimetry between tandem-ovoid and 
tandem-ring gynaecologic brachytherapy applicators in image 
guided brachytherapy 
